[Clinical analysis of gene mutation characteristics and mutation burden in myelodysplastic syndrome].

Lü, X D; Li, Y W; Guo, Z; Xin, Y P; Hu, J Y; Fan, R H; Song, Y P

Lü, X D; Li, Y W; Guo, Z; Xin, Y P; Hu, J Y; Fan, R H; Song, Y P.

Afiliação

Lü XD; Central Laboratory, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.
Li YW; Central Laboratory, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.
Guo Z; Central Laboratory, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.
Xin YP; Department of Endocrinology, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450014, China.
Hu JY; Central Laboratory, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.
Fan RH; Central Laboratory, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.
Song YP; Central Laboratory, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450008, China.

Zhonghua Yi Xue Za Zhi ; 100(12): 933-937, 2020 Mar 31.

Article em Zh | MEDLINE | ID: mdl-32234169

Assuntos

Leucemia Mieloide Aguda; Síndromes Mielodisplásicas; Adulto; Idoso; Humanos; Cariótipo; Pessoa de Meia-Idade; Mutação; Síndromes Mielodisplásicas/genética; Nucleofosmina; Prognóstico

Palavras-chave

Gene mutation; High-throughput sequencing; Mutation burden; Myelodysplastic syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Humans / Middle aged Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google